Here, we discovered that HIF-1α and HECTD2 were enhanced in RCC, and in-vivo studies testified that overexpressing HECTD2 and HIF-1α hampered apoptosis and induced tumor growth of RCC cells. Here, HIF1A is linked to renal cell adenocarcinoma.